Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Goodwill (2016 - 2025)

Plus Therapeutics has reported Goodwill over the past 16 years, most recently at $372000.0 for Q4 2025.

  • Quarterly Goodwill changed 0.0% to $372000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $372000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $372000.0 for FY2025, 0.0% changed from the prior year.
  • Goodwill was $372000.0 for Q4 2025 at Plus Therapeutics, roughly flat from $372000.0 in the prior quarter.
  • Over five years, Goodwill peaked at $372000.0 in Q1 2021 and troughed at $372000.0 in Q1 2021.
  • The 5-year median for Goodwill is $372000.0 (2021), against an average of $372000.0.
  • The largest YoY upside for Goodwill was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
  • A 5-year view of Goodwill shows it stood at $372000.0 in 2021, then changed by 0.0% to $372000.0 in 2022, then changed by 0.0% to $372000.0 in 2023, then changed by 0.0% to $372000.0 in 2024, then changed by 0.0% to $372000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Goodwill are $372000.0 (Q4 2025), $372000.0 (Q3 2025), and $372000.0 (Q2 2025).